High throughput siRNA Screening of the Human Kinome Identifies Novel Kinases Controlling the Canonical NF-kB Activation Pathway
News Sep 20, 2011
Nuclear Factor-κB (NF-κB) is an inducible cytoplasmic transcription factor that plays a role as a master regulator of airway mucosal inflammation. The prototypical (canonical) NF-κB pathway controls cytoplasmic to nuclear translocation in response to stimulation by the mononuclear cytokine, TNF. Despite intensive investigation, the spectrum of kinases involved in the canonical NF-κB pathway has not yet been systematically determined. Here we have applied a high throughput-siRNA (HT-siRNA)-mediated loss-of-function screening assay to identify novel kinases important in TNF-induced NF-κB signaling. Type II A549 epithelial cells stably expressing an IL-8/Luciferase reporter gene optimized for HT-siRNA format (Z prime score of 0.65) and siRNAs for 636 human kinases were reverse-transfected and screened in the assay. 36 candidate genes were identified that inhibited TNF signaling with a z score deviation of <-1.3 in replicate plates. From this group, 11 kinases were selected for independent validation, of which 8 were successfully silenced. Six kinases were validated, including ATM, CDK2,-5 and -7, CALM3, MAPAKP5, and MAP3K/MEKK3. The surprising function of ATM in TNF signaling was confirmed where reduced NF-kB/RelA translocation and Ser 276 phosphorylation was seen in ATM(-/-)MEFs. These data indicate that ATM is a key regulatory kinase that may control global NF-κB activation in the TNF-induced canonical pathway.
The article is published online in the Journal of Biological Chemistry and is free to access.
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019
International Women Health and Breast Cancer Conference
Jul 03 - Jul 05, 2019
2nd International Conference on Biological & Pharmaceutical Sciences
Jul 12 - Jul 13, 2019